Process Plus Marketing

Process Plus Marketing company information, Employees & Contact Information

Process Plus is a boutique growth marketing firm that incorporates strategy and innovation in finding success for our customers. We integrate deeply into your organization to carve out a unique plan tailored to you.

Company Details

Employees
22
Founded
-
Address
Toronto, On, Ca
Industry
Marketing Services
NAICS
Advertising, Public Relations, and Related Services
Advertising Agencies
Media Buying Agencies
Media Representatives
Outdoor Advertising
Direct Mail Advertising
Advertising Material Distribution Services
Other Services Related to Advertising
Keywords
Toronto.
HQ
Toronto, ON
Looking for a particular Process Plus Marketing employee's phone or email?

Process Plus Marketing Questions

News

Dr Faivre-Finn on Areas of Debate Surrounding Concurrent Chemoradiotherapy Plus IO in LS-SCLC - OncLive

Dr Faivre-Finn on Areas of Debate Surrounding Concurrent Chemoradiotherapy Plus IO in LS-SCLC OncLive

Chemo Plus IO Offers Survival Benefit in ES-SCLC vs Chemo Alone in Real-World Study - The American Journal of Managed Care® (AJMC®)

Chemo Plus IO Offers Survival Benefit in ES-SCLC vs Chemo Alone in Real-World Study The American Journal of Managed Care® (AJMC®)

IO/IO Vs IO/TKI Usage in Frontline RCC Varies Across Clinical Practice - Targeted Oncology

IO/IO Vs IO/TKI Usage in Frontline RCC Varies Across Clinical Practice Targeted Oncology

5 YRS AGO – NXT TV Report (7-29-2020): Swerve vs. Atlas, Dexter Lumis vs. Finn Balor vs. Timothy Thatcher, plus Io Shirai, Candice LeRae, Gargano, Strong, Shotzi, Keith Lee - PWTorch

5 YRS AGO – NXT TV Report (7-29-2020): Swerve vs. Atlas, Dexter Lumis vs. Finn Balor vs. Timothy Thatcher, plus Io Shirai, Candice LeRae, Gargano, Strong, Shotzi, Keith Lee PWTorch

IO-202 Plus Azacitidine Could Bring Long-Awaited Change in HMA-Naive CMML - OncLive

IO-202 Plus Azacitidine Could Bring Long-Awaited Change in HMA-Naive CMML OncLive

Pivotal Immunotherapy Data Hit Advanced Kidney Cancer Practice - Oncology News Central

Pivotal Immunotherapy Data Hit Advanced Kidney Cancer Practice Oncology News Central

Systemic therapy after adjuvant IO shows benefit in subset of renal cell carcinoma tumors - Urology Times

Systemic therapy after adjuvant IO shows benefit in subset of renal cell carcinoma tumors Urology Times

Combination Lenvatinib-Tislelizumab for Fumarate Hydratase-Deficient Renal Cell Carcinoma - Wen Kong - UroToday

Combination Lenvatinib-Tislelizumab for Fumarate Hydratase-Deficient Renal Cell Carcinoma - Wen Kong UroToday

NewTek announces New NDI® Spark Plus IO Converters - Newsshooter

NewTek announces New NDI® Spark Plus IO Converters Newsshooter

Weighing IO Plus TKI Combinations in Advanced RCC - Targeted Oncology

Weighing IO Plus TKI Combinations in Advanced RCC Targeted Oncology

How Best to Treat Recurrent RCC After Adjuvant Immunotherapy? New Study Offers Insights - Oncology News Central

How Best to Treat Recurrent RCC After Adjuvant Immunotherapy? New Study Offers Insights Oncology News Central

Laurence Albiges, MD, on COSMIC-313 trial of triplet vs doublet combination in aRCC - Urology Times

Laurence Albiges, MD, on COSMIC-313 trial of triplet vs doublet combination in aRCC Urology Times

Dr Tan on the Efficacy and Safety of IO-IO and IO-TKI Combination Regimens in RCC - OncLive

Dr Tan on the Efficacy and Safety of IO-IO and IO-TKI Combination Regimens in RCC OncLive

Comparing Long-Term Data for IO/IO and IO/TKI in Favorable-Risk mRCC - Targeted Oncology

Comparing Long-Term Data for IO/IO and IO/TKI in Favorable-Risk mRCC Targeted Oncology

Pembrolizumab Plus Sacituzumab Govitecan Shows Nonsignificant Trend Toward Improved PFS in HR+ Breast Cancer - OncLive

Pembrolizumab Plus Sacituzumab Govitecan Shows Nonsignificant Trend Toward Improved PFS in HR+ Breast Cancer OncLive

Survival Benefit of IO Added to Standard Chemotherapy in Gastric/GEJ/Esophageal Cancers - Targeted Oncology

Survival Benefit of IO Added to Standard Chemotherapy in Gastric/GEJ/Esophageal Cancers Targeted Oncology

Comparing Choices for IO/TKI Combinations in Advanced RCC - Targeted Oncology

Comparing Choices for IO/TKI Combinations in Advanced RCC Targeted Oncology

IO and VEGF Inhibition in Hepatocellular Carcinoma - OncLive

IO and VEGF Inhibition in Hepatocellular Carcinoma OncLive

Vokes Explores Biomarker Testing and Treatment Landscape for EGFR-Mutated Lung Cancer - Targeted Oncology

Vokes Explores Biomarker Testing and Treatment Landscape for EGFR-Mutated Lung Cancer Targeted Oncology

Comparing IO/IO and IO/TKI Frontline Regimens in Clear Cell RCC - Targeted Oncology

Comparing IO/IO and IO/TKI Frontline Regimens in Clear Cell RCC Targeted Oncology

Giles discusses the path forward using artificial intelligence - New Mexico State University

Giles discusses the path forward using artificial intelligence New Mexico State University

NRG-GY018 Trial to Rule Benefit of IO/Chemo in Advanced Endometrial Cancer - CancerNetwork

NRG-GY018 Trial to Rule Benefit of IO/Chemo in Advanced Endometrial Cancer CancerNetwork

The Xbox handheld may not do huge numbers. But that's not the point - The Game Business

The Xbox handheld may not do huge numbers. But that's not the point The Game Business

Immunotherapy for Patients With Lynch Syndrome and CRC: Treating Based on MMR/MSI Status - ASCO Daily News

Immunotherapy for Patients With Lynch Syndrome and CRC: Treating Based on MMR/MSI Status ASCO Daily News

New Bike Day: Haro Shift Plus i/O 5 Trail Bike - Mountain Bike Action Magazine

New Bike Day: Haro Shift Plus i/O 5 Trail Bike Mountain Bike Action Magazine

CLEAR Study: First-Line Lenvatinib Plus Pembrolizumab Maintains Advantage Over Sunitinib in Advanced RCC at Long-Term Follow-up - ASCO Daily News

CLEAR Study: First-Line Lenvatinib Plus Pembrolizumab Maintains Advantage Over Sunitinib in Advanced RCC at Long-Term Follow-up ASCO Daily News

Clinical Perspectives on the Evolution of Non-small Cell Lung Cancer Treatment With Immuno-oncology and ROS1 Tyrosine Kinase Inhibitors - European Medical Journal

Clinical Perspectives on the Evolution of Non-small Cell Lung Cancer Treatment With Immuno-oncology and ROS1 Tyrosine Kinase Inhibitors European Medical Journal

Neoadjuvant durvalumab plus SBRT safe, effective for lung cancer subset - Healio

Neoadjuvant durvalumab plus SBRT safe, effective for lung cancer subset Healio

New IO 4K Plus and AJA Avid | Artist DNxIV - The American Society of Cinematographers

New IO 4K Plus and AJA Avid | Artist DNxIV The American Society of Cinematographers

Combining Belzutifan Plus Cabozantinib in Advanced Clear Cell Renal Cell Carcinoma, Exploring Novel Therapy Options - Toni Choueiri - UroToday

Combining Belzutifan Plus Cabozantinib in Advanced Clear Cell Renal Cell Carcinoma, Exploring Novel Therapy Options - Toni Choueiri UroToday

Lenvatinib/Everolimus Shows Potential as Second-Line Therapy After CheckMate 9ER Regimen in RCC - Targeted Oncology

Lenvatinib/Everolimus Shows Potential as Second-Line Therapy After CheckMate 9ER Regimen in RCC Targeted Oncology

Emerson's IO-Link Master Reduces Hardware Costs, Future-Proofs Pneumatic Valve Systems with IIoT Integration - Automation.com

Emerson's IO-Link Master Reduces Hardware Costs, Future-Proofs Pneumatic Valve Systems with IIoT Integration Automation.com

AJA Io X3 Announced – Multi-Channel 2K Video & Audio I/O via Thunderbolt 3 - CineD

AJA Io X3 Announced – Multi-Channel 2K Video & Audio I/O via Thunderbolt 3 CineD

ABB’s latest distributed control system release helps accelerate digital transformation in process automation - ABB

ABB’s latest distributed control system release helps accelerate digital transformation in process automation ABB

Deep dive: A close look at the TUF Gaming B850-Plus WiFi motherboard - ASUS

Deep dive: A close look at the TUF Gaming B850-Plus WiFi motherboard ASUS

AJA ships new KONA cards and Thunderbolt 3 Io IP by Jose Antunes - ProVideo Coalition - ProVideo Coalition

AJA ships new KONA cards and Thunderbolt 3 Io IP by Jose Antunes - ProVideo Coalition ProVideo Coalition

Radiotherapy combined with PD-1/PD-L1 inhibitors in NSCLC brain metastases treatment: The mechanisms, advances, opportunities, and challenges - Wiley Online Library

Radiotherapy combined with PD-1/PD-L1 inhibitors in NSCLC brain metastases treatment: The mechanisms, advances, opportunities, and challenges Wiley Online Library

AMD’s 96-core Threadripper Pro 9995WX pulls 947W when overclocked - Club386

AMD’s 96-core Threadripper Pro 9995WX pulls 947W when overclocked Club386

Hitman 3 Is Going Rogue(like) - Kotaku

Hitman 3 Is Going Rogue(like) Kotaku

The versatility of AJA’s solutions saves Hash Pixel time and money - Panorama Audiovisual

The versatility of AJA’s solutions saves Hash Pixel time and money Panorama Audiovisual

Dell XPS 13 Plus Review : Where are all the IO options? - digit.in

Dell XPS 13 Plus Review : Where are all the IO options? digit.in

Dell OptiPlex 7410 AIO Plus Review - StorageReview.com

Dell OptiPlex 7410 AIO Plus Review StorageReview.com

Haro Shift Plus i/O 9 review – an eMTB with BMX genes? - E-MOUNTAINBIKE Magazine

Haro Shift Plus i/O 9 review – an eMTB with BMX genes? E-MOUNTAINBIKE Magazine

Fanafintohinana fifanarahana indroa tao amin'ny hopitaly Gjilan: Nandika lalàna sy andrim-panjakana mangina - Indeksonline.

Fanafintohinana fifanarahana indroa tao amin'ny hopitaly Gjilan: Nandika lalàna sy andrim-panjakana mangina Indeksonline.

MSI X299 SLI Plus Review - PCMag

MSI X299 SLI Plus Review PCMag

Google’s Facebook Competitor, The Google+ Social Network, Finally Arrives - Search Engine Land

Google’s Facebook Competitor, The Google+ Social Network, Finally Arrives Search Engine Land

Nintendo Switch 2: AAA Games Avalanche Incoming Final Fantasy 7 Remake, Cyberpunk 2077 & More - Technetbook

Nintendo Switch 2: AAA Games Avalanche Incoming Final Fantasy 7 Remake, Cyberpunk 2077 & More Technetbook

Top Process Plus Marketing Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant